Important note

This AI stock analysis for Elevance Health is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Elevance Health - AI Stock Analysis

Analysis generated November 17, 2024

Elevance Health, formerly known as Anthem Inc., is a leading health benefits company focused on improving the health of its 40 million members across the United States. The company operates through its extensive provider network to offer a broad range of health insurance plans, consulting services, and other health-related products and services. Elevance Health seeks to achieve better health outcomes and reduce overall healthcare costs for its customers.

Fundamental Analysis

For the last quarter, Elevance Health reported revenue of $45.1 billion, representing a 2.78% increase from the previous quarter and a 5.27% rise compared to the same quarter last year. This consistent revenue growth is a positive indicator of the company's demand and market strength.

Net income for the last quarter was $1.02 billion, reflecting a significant decrease of 55.83% compared to the previous quarter and a 21.18% decline year over year. This repeated drop in net income is concerning and calls for additional scrutiny into the causes, such as increased operational costs or other financial challenges.

EBITDA for the last quarter stood at $1.8 billion, demonstrating a decrease of 47.39% from the previous quarter and a 14.71% decline compared to the same quarter last year. These trends mirror the net income figures and suggest potential issues with the company’s profitability.

The current Price-to-Earnings (P/E) ratio is 14.58, indicating that the stock is not particularly overvalued or undervalued. It presents a relatively normal valuation range, offering no clear buy or sell signal purely based on this metric.

Technical Analysis

The current stock price of Elevance Health is $400.69. This represents a 9.83% decrease from a month ago and a 12.37% decrease over the past year, which could be concerning for both short-term and long-term investors.

The stock's trend is currently bearish. The SMA10 is 412.62, which is lower than the previous SMA10 of 415.48, indicating a potential downward trend. Additionally, the Relative Strength Index (RSI) stands at 70.4, suggesting an overbought condition that might predict further bearish movements.

Alternative Data Analysis

Job postings for Elevance Health have increased by 114% over the last couple of months, reaching 844 open positions. This indicates a potential growth and expansion phase, which is a positive sign for the company's future operations and scaling efforts.

In terms of customer acquisition, Elevance Health has maintained a steady influx of approximately 370,000 visitors to their webpage, without a significant change. Mobile app downloads have also remained stagnant. These flat metrics suggest that customer engagement efforts are not currently driving further growth.

On social media, Elevance Health has 35,000 followers on Twitter. However, the number of followers has decreased by 1% in recent months, potentially indicating a decline in public interest or engagement with the company.

AltIndex’s AI score, which incorporates fundamental, technical, and alternative data analysis, gives Elevance Health a score of 49, suggesting a hold recommendation.

Conclusion and Recommendation

Taking into account the fundamental, technical, and alternative data analysis, Elevance Health presents a mixed outlook. Revenue growth is a strong positive, but substantial decreases in net income and EBITDA are concerning. From a technical standpoint, the bearish trend and high RSI indicate potential further short-term declines. Alternative data shows promising signs of expansion in employee hiring but lacks strong growth in customer engagement.

Given the current situation, a cautious approach is advisable. The hold recommendation suggested by the AltIndex AI score seems prudent. Investors may want to wait for clearer signs of profitability improvement and better engagement metrics before considering an optimistic outlook on Elevance Health.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.